DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis

Tohru Nakagawa, Yae Kanai, Saori Ushijima, Tadaichi Kitamura, Tadao Kakizoe, Setsuo Hirohashi

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Purpose: We elucidated the significance of aberrant DNA methylation on multiple CpG islands and its correlation with DNA methyltransferase DNMT1 protein expression during urothelial carcinogenesis. Materials and Methods: We examined the DNA methylation status on multiple CpG islands by methylation specific polymerase chain reaction and combined bisulfite restriction enzyme analysis in 12 specimens of normal urothelium, 23 of noncancerous urothelium showing no remarkable histological changes obtained from patients with bladder cancer (NBC) and 70 of transitional cell carcinoma (TCC). Results: DNA methylation on CpG islands of the p16 (0%, 17% and 21%) and death-associated protein kinase (13%, 33% and 29%) genes, and methylated in tumor-2 (56%, 60% and 76%), 12 (0%, 6% and 30%), 25 (25%, 27% and 35%) and 31 (45%, 56% and 79%) clones was detected in normal urothelium, NBCs and TCCs, respectively. The incidence of concurrent DNA hypermethylation on 3 or more CpG islands in NBCs (38%) was significantly higher than that in normal urothelium (0%, p = 0.0455) and even higher in TCCs (59%, p = 0.0043). The incidence of the CpG island methylator phenotype in nonpapillary carcinomas (nodular invasive carcinomas and their precursors, ie flat carcinoma in situ, 71%) was significantly higher than in papillary carcinomas (40%, p = 0.0143). In all specimens examined concurrent DNA hypermethylation on 3 or more CpG islands significantly correlated with immunohistochemically evaluated DNMT1 protein over expression (p = 0.0167). Conclusions: DNA hypermethylation on multiple CpG islands in association with DNMT1 protein over expression may participate in multistage urothelial carcinogenesis even at the precancerous stage and particularly in the development of nodular invasive carcinomas of the bladder.

Original languageEnglish
Pages (from-to)1767-1771
Number of pages5
JournalJournal of Urology
Volume173
Issue number5
DOIs
Publication statusPublished - 2005 May
Externally publishedYes

Fingerprint

Protein Methyltransferases
CpG Islands
Carcinogenesis
Urothelium
DNA
DNA Methylation
Carcinoma
Death-Associated Protein Kinases
Restriction Mapping
Transitional Cell Carcinoma
Papillary Carcinoma
Incidence
Carcinoma in Situ
Urinary Bladder Neoplasms
Methylation
Urinary Bladder
Proteins
Clone Cells
Phenotype
Polymerase Chain Reaction

Keywords

  • Bladder
  • Carcinoma, transitional cell
  • CpG islands
  • DNA
  • Phenotype

ASJC Scopus subject areas

  • Urology

Cite this

DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. / Nakagawa, Tohru; Kanai, Yae; Ushijima, Saori; Kitamura, Tadaichi; Kakizoe, Tadao; Hirohashi, Setsuo.

In: Journal of Urology, Vol. 173, No. 5, 05.2005, p. 1767-1771.

Research output: Contribution to journalArticle

Nakagawa, Tohru ; Kanai, Yae ; Ushijima, Saori ; Kitamura, Tadaichi ; Kakizoe, Tadao ; Hirohashi, Setsuo. / DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. In: Journal of Urology. 2005 ; Vol. 173, No. 5. pp. 1767-1771.
@article{a35ddd3dda414d9db55119b6c2283584,
title = "DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis",
abstract = "Purpose: We elucidated the significance of aberrant DNA methylation on multiple CpG islands and its correlation with DNA methyltransferase DNMT1 protein expression during urothelial carcinogenesis. Materials and Methods: We examined the DNA methylation status on multiple CpG islands by methylation specific polymerase chain reaction and combined bisulfite restriction enzyme analysis in 12 specimens of normal urothelium, 23 of noncancerous urothelium showing no remarkable histological changes obtained from patients with bladder cancer (NBC) and 70 of transitional cell carcinoma (TCC). Results: DNA methylation on CpG islands of the p16 (0{\%}, 17{\%} and 21{\%}) and death-associated protein kinase (13{\%}, 33{\%} and 29{\%}) genes, and methylated in tumor-2 (56{\%}, 60{\%} and 76{\%}), 12 (0{\%}, 6{\%} and 30{\%}), 25 (25{\%}, 27{\%} and 35{\%}) and 31 (45{\%}, 56{\%} and 79{\%}) clones was detected in normal urothelium, NBCs and TCCs, respectively. The incidence of concurrent DNA hypermethylation on 3 or more CpG islands in NBCs (38{\%}) was significantly higher than that in normal urothelium (0{\%}, p = 0.0455) and even higher in TCCs (59{\%}, p = 0.0043). The incidence of the CpG island methylator phenotype in nonpapillary carcinomas (nodular invasive carcinomas and their precursors, ie flat carcinoma in situ, 71{\%}) was significantly higher than in papillary carcinomas (40{\%}, p = 0.0143). In all specimens examined concurrent DNA hypermethylation on 3 or more CpG islands significantly correlated with immunohistochemically evaluated DNMT1 protein over expression (p = 0.0167). Conclusions: DNA hypermethylation on multiple CpG islands in association with DNMT1 protein over expression may participate in multistage urothelial carcinogenesis even at the precancerous stage and particularly in the development of nodular invasive carcinomas of the bladder.",
keywords = "Bladder, Carcinoma, transitional cell, CpG islands, DNA, Phenotype",
author = "Tohru Nakagawa and Yae Kanai and Saori Ushijima and Tadaichi Kitamura and Tadao Kakizoe and Setsuo Hirohashi",
year = "2005",
month = "5",
doi = "10.1097/01.ju.0000154632.11824.4d",
language = "English",
volume = "173",
pages = "1767--1771",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis

AU - Nakagawa, Tohru

AU - Kanai, Yae

AU - Ushijima, Saori

AU - Kitamura, Tadaichi

AU - Kakizoe, Tadao

AU - Hirohashi, Setsuo

PY - 2005/5

Y1 - 2005/5

N2 - Purpose: We elucidated the significance of aberrant DNA methylation on multiple CpG islands and its correlation with DNA methyltransferase DNMT1 protein expression during urothelial carcinogenesis. Materials and Methods: We examined the DNA methylation status on multiple CpG islands by methylation specific polymerase chain reaction and combined bisulfite restriction enzyme analysis in 12 specimens of normal urothelium, 23 of noncancerous urothelium showing no remarkable histological changes obtained from patients with bladder cancer (NBC) and 70 of transitional cell carcinoma (TCC). Results: DNA methylation on CpG islands of the p16 (0%, 17% and 21%) and death-associated protein kinase (13%, 33% and 29%) genes, and methylated in tumor-2 (56%, 60% and 76%), 12 (0%, 6% and 30%), 25 (25%, 27% and 35%) and 31 (45%, 56% and 79%) clones was detected in normal urothelium, NBCs and TCCs, respectively. The incidence of concurrent DNA hypermethylation on 3 or more CpG islands in NBCs (38%) was significantly higher than that in normal urothelium (0%, p = 0.0455) and even higher in TCCs (59%, p = 0.0043). The incidence of the CpG island methylator phenotype in nonpapillary carcinomas (nodular invasive carcinomas and their precursors, ie flat carcinoma in situ, 71%) was significantly higher than in papillary carcinomas (40%, p = 0.0143). In all specimens examined concurrent DNA hypermethylation on 3 or more CpG islands significantly correlated with immunohistochemically evaluated DNMT1 protein over expression (p = 0.0167). Conclusions: DNA hypermethylation on multiple CpG islands in association with DNMT1 protein over expression may participate in multistage urothelial carcinogenesis even at the precancerous stage and particularly in the development of nodular invasive carcinomas of the bladder.

AB - Purpose: We elucidated the significance of aberrant DNA methylation on multiple CpG islands and its correlation with DNA methyltransferase DNMT1 protein expression during urothelial carcinogenesis. Materials and Methods: We examined the DNA methylation status on multiple CpG islands by methylation specific polymerase chain reaction and combined bisulfite restriction enzyme analysis in 12 specimens of normal urothelium, 23 of noncancerous urothelium showing no remarkable histological changes obtained from patients with bladder cancer (NBC) and 70 of transitional cell carcinoma (TCC). Results: DNA methylation on CpG islands of the p16 (0%, 17% and 21%) and death-associated protein kinase (13%, 33% and 29%) genes, and methylated in tumor-2 (56%, 60% and 76%), 12 (0%, 6% and 30%), 25 (25%, 27% and 35%) and 31 (45%, 56% and 79%) clones was detected in normal urothelium, NBCs and TCCs, respectively. The incidence of concurrent DNA hypermethylation on 3 or more CpG islands in NBCs (38%) was significantly higher than that in normal urothelium (0%, p = 0.0455) and even higher in TCCs (59%, p = 0.0043). The incidence of the CpG island methylator phenotype in nonpapillary carcinomas (nodular invasive carcinomas and their precursors, ie flat carcinoma in situ, 71%) was significantly higher than in papillary carcinomas (40%, p = 0.0143). In all specimens examined concurrent DNA hypermethylation on 3 or more CpG islands significantly correlated with immunohistochemically evaluated DNMT1 protein over expression (p = 0.0167). Conclusions: DNA hypermethylation on multiple CpG islands in association with DNMT1 protein over expression may participate in multistage urothelial carcinogenesis even at the precancerous stage and particularly in the development of nodular invasive carcinomas of the bladder.

KW - Bladder

KW - Carcinoma, transitional cell

KW - CpG islands

KW - DNA

KW - Phenotype

UR - http://www.scopus.com/inward/record.url?scp=17144413410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144413410&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000154632.11824.4d

DO - 10.1097/01.ju.0000154632.11824.4d

M3 - Article

C2 - 15821584

AN - SCOPUS:17144413410

VL - 173

SP - 1767

EP - 1771

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -